메뉴 건너뛰기




Volumn 60, Issue 1, 2014, Pages 5-13

Recommendations for liver biopsy evaluation in non-alcoholic fatty liver disease

Author keywords

Fatty liver; Liver diseases; Non alcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C;

EID: 84899696701     PISSN: 1121421X     EISSN: 18271642     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (15)

References (47)
  • 1
    • 0036829092 scopus 로고    scopus 로고
    • AGA technical review on nonalcoholic fatty liver disease
    • Sanyal AJ. AGA technical review on non-alcoholic fatty liver disease. Gastroenterology 2002;123:1705-25. (Pubitemid 35231670)
    • (2002) Gastroenterology , vol.123 , Issue.5 , pp. 1705-1725
    • Sanyal, A.J.1
  • 2
    • 84861901590 scopus 로고    scopus 로고
    • The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    • Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol 2012;107:811-26.
    • (2012) Am J Gastroenterol , vol.107 , pp. 811-826
    • Chalasani, N.1    Younossi, Z.2    Lavine, J.E.3    Diehl, A.M.4    Brunt, E.M.5    Cusi, K.6
  • 5
    • 3342958806 scopus 로고    scopus 로고
    • Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis
    • DOI 10.2337/diacare.27.8.2057
    • Medina J, Fernandez-Salazar LI, Garcia-Buey L, Moreno-Otero R. Approach to the pathogenesis and treatment of non-alcoholic steatohepatitis. Diabetes Care 2004;27:2057-66. (Pubitemid 38989257)
    • (2004) Diabetes Care , vol.27 , Issue.8 , pp. 2057-2066
    • Medina, J.1    Fernandez-Salazar, L.I.2    Garcia-Buey, L.3    Moreno-Otero, R.4
  • 6
    • 74549140993 scopus 로고    scopus 로고
    • Prevalence and trends in obesity among US adults, 1999-2008
    • Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-41.
    • (2010) JAMA , vol.303 , pp. 235-241
    • Flegal, K.M.1    Carroll, M.D.2    Ogden, C.L.3    Curtin, L.R.4
  • 7
    • 79959478969 scopus 로고    scopus 로고
    • Clinical practice. Chronic hepatitis C infection
    • Rosen HR. Clinical practice. Chronic hepatitis C infection. N Engl J Med 2011;364:2429-38.
    • (2011) N Engl J Med , vol.364 , pp. 2429-2438
    • Rosen, H.R.1
  • 8
    • 79960029926 scopus 로고    scopus 로고
    • Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
    • Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34:274-85.
    • (2011) Aliment Pharmacol Ther , vol.34 , pp. 274-285
    • Vernon, G.1    Baranova, A.2    Younossi, Z.M.3
  • 9
    • 78650486196 scopus 로고    scopus 로고
    • Prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study
    • Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M et al. Prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124-31.
    • (2011) Gastroenterology , vol.140 , pp. 124-131
    • Williams, C.D.1    Stengel, J.2    Asike, M.I.3    Torres, D.M.4    Shaw, J.5    Contreras, M.6
  • 10
    • 70349770695 scopus 로고    scopus 로고
    • Epidemiology and natural history of non-alcoholic steatohepatitis
    • Argo CK, Caldwell SH. Epidemiology and natural history of non-alcoholic steatohepatitis. Clin Liver Dis 2009;13:511-31.
    • (2009) Clin Liver Dis , vol.13 , pp. 511-531
    • Argo, C.K.1    Caldwell, S.H.2
  • 12
    • 77952730428 scopus 로고    scopus 로고
    • The incidence and risk factors of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
    • Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. Hepatology 2010;51:1972-8.
    • (2010) Hepatology , vol.51 , pp. 1972-1978
    • Ascha, M.S.1    Hanouneh, I.A.2    Lopez, R.3    Tamimi, T.A.4    Feldstein, A.F.5    Zein, N.N.6
  • 13
    • 22344452893 scopus 로고    scopus 로고
    • The natural history of nonalcoholic fatty liver disease: A population-based cohort study
    • DOI 10.1053/j.gastro.2005.04.014, PII S0016508505006943
    • Adams LA, Lymp JF, St SJ, Sanderson SO, Lindor KD, Feldstein A et al. The natural history of non-alcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129:113-21. (Pubitemid 41002048)
    • (2005) Gastroenterology , vol.129 , Issue.1 , pp. 113-121
    • Adams, L.A.1    Lymp, J.F.2    St, S.J.3    Sanderson, S.O.4    Lindor, K.D.5    Feldstein, A.6    Angulo, P.7
  • 14
    • 50649094716 scopus 로고    scopus 로고
    • Suspected non-alcoholic fatty liver disease and mortality risk in a population-based cohort study
    • Dunn W, Xu R, Wingard DL, Rogers C, Angulo P, Younossi ZM et al. Suspected non-alcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008;103:2263-71.
    • (2008) Am J Gastroenterol , vol.103 , pp. 2263-2271
    • Dunn, W.1    Xu, R.2    Wingard, D.L.3    Rogers, C.4    Angulo, P.5    Younossi, Z.M.6
  • 16
    • 0032695030 scopus 로고    scopus 로고
    • Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis
    • Angulo P, Reach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis. Hepatology 1999;30:1356-62.
    • (1999) Hepatology , vol.30 , pp. 1356-1362
    • Angulo, P.1    Reach, J.C.2    Batts, K.P.3    Lindor, K.D.4
  • 17
    • 33747503550 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease presenting with an isolated elevated alkaline phosphatase
    • DOI 10.1097/00004836-200608000-00015, PII 0000483620060800000015
    • Pantsari MW, Harrison SA. Non-alcoholic fatty liver disease presenting with an isolated elevated alkaline phosphatase. J Clin Gastroenterol 2006;40:633-635. (Pubitemid 44259772)
    • (2006) Journal of Clinical Gastroenterology , vol.40 , Issue.7 , pp. 633-635
    • Pantsari, M.W.1    Harrison, S.A.2
  • 18
    • 84888298670 scopus 로고    scopus 로고
    • Longitudinal comparison between MRI, MRS and histology-determined steatosis in NAFLD patients at two-time points in a randomized trial
    • Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA et al. Longitudinal comparison between MRI, MRS and histology-determined steatosis in NAFLD patients at two-time points in a randomized trial. Hepatology 2013;58:1930-40.
    • (2013) Hepatology , vol.58 , pp. 1930-1940
    • Noureddin, M.1    Lam, J.2    Peterson, M.R.3    Middleton, M.4    Hamilton, G.5    Le, T.A.6
  • 19
    • 85027925485 scopus 로고    scopus 로고
    • Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD
    • Permutt Z, Le TA, Peterson MR, Seki E, Brenner DA, Sirlin C et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 2012;36:22-9.
    • (2012) Aliment Pharmacol Ther , vol.36 , pp. 22-29
    • Permutt, Z.1    Le, T.A.2    Peterson, M.R.3    Seki, E.4    Brenner, D.A.5    Sirlin, C.6
  • 20
    • 84865569519 scopus 로고    scopus 로고
    • Effect of colesevelam on liver fat quantified by magnetic resonance in non-alcoholic steatohepatitis: A randomized controlled trial
    • Le TA, Chen J, Changchien C, Peterson MR, Kono Y, Patton H et al. Effect of colesevelam on liver fat quantified by magnetic resonance in non-alcoholic steatohepatitis: a randomized controlled trial. Hepatology 2012;56:922-32.
    • (2012) Hepatology , vol.56 , pp. 922-932
    • Le, T.A.1    Chen, J.2    Changchien, C.3    Peterson, M.R.4    Kono, Y.5    Patton, H.6
  • 21
    • 84863679715 scopus 로고    scopus 로고
    • What should we recommend to our patients with NAFLD regarding alcohol use?
    • Liangpunsakul S, Chalasani N. What should we recommend to our patients with NAFLD regarding alcohol use? Am J Gastroenterol 2012;107:976-8.
    • (2012) Am J Gastroenterol , vol.107 , pp. 976-978
    • Liangpunsakul, S.1    Chalasani, N.2
  • 22
    • 77649337140 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease: Pathology and pathogenesis
    • Tiniakos DG, Vos MB, Brunt EM. Non-alcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 2010;5:145-71.
    • (2010) Annu Rev Pathol , vol.5 , pp. 145-171
    • Tiniakos, D.G.1    Vos, M.B.2    Brunt, E.M.3
  • 23
    • 79251535913 scopus 로고    scopus 로고
    • Non-invasive diagnosis of non-alcoholic fatty liver and non-alcoholic steatohepatitis
    • Adams LA, Feldstein AE. Non-invasive diagnosis of non-alcoholic fatty liver and non-alcoholic steatohepatitis. J Dig Dis 2011;12:10-6.
    • (2011) J Dig Dis , vol.12 , pp. 10-16
    • Adams, L.A.1    Feldstein, A.E.2
  • 24
    • 80555136061 scopus 로고    scopus 로고
    • Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
    • Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43:617-49.
    • (2011) Ann Med , vol.43 , pp. 617-649
    • Musso, G.1    Gambino, R.2    Cassader, M.3    Pagano, G.4
  • 28
    • 84865545850 scopus 로고    scopus 로고
    • Association between diabetes, family history of diabetes, and risk of non-alcoholic steatohepatitis and fibrosis
    • Loomba R, Abraham M, Unalp A, Wilson L, Lavine J, Doo E et al. Association between diabetes, family history of diabetes, and risk of non-alcoholic steatohepatitis and fibrosis. Hepatology 2012;56:943-51.
    • (2012) Hepatology , vol.56 , pp. 943-951
    • Loomba, R.1    Abraham, M.2    Unalp, A.3    Wilson, L.4    Lavine, J.5    Doo, E.6
  • 29
    • 84887025674 scopus 로고    scopus 로고
    • Clinical and histological determinants of non-alcoholic steatohepatitis and advanced fibrosis in elderly patients
    • Epub ahead of print
    • Noureddin M, Yates KP, Vaughn IA, Neuschwander-Tetri BA, Sanyal AJ, McCullough A et al. Clinical and histological determinants of non-alcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology 2013 [Epub ahead of print].
    • (2013) Hepatology
    • Noureddin, M.1    Yates, K.P.2    Vaughn, I.A.3    Neuschwander-Tetri, B.A.4    Sanyal, A.J.5    McCullough, A.6
  • 30
    • 79251524594 scopus 로고    scopus 로고
    • Systematic review: The diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    • Dowman JK, Tomlinson JW, Newsome PN. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2011;33:525-40.
    • (2011) Aliment Pharmacol Ther , vol.33 , pp. 525-540
    • Dowman, J.K.1    Tomlinson, J.W.2    Newsome, P.N.3
  • 31
    • 84155188801 scopus 로고    scopus 로고
    • Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with non-alcoholic fatty liver disease
    • Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander-Tetri BA, Chalasani N et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with non-alcoholic fatty liver disease. Hepatology 2012;55:77-85.
    • (2012) Hepatology , vol.55 , pp. 77-85
    • Kowdley, K.V.1    Belt, P.2    Wilson, L.A.3    Yeh, M.M.4    Neuschwander-Tetri, B.A.5    Chalasani, N.6
  • 32
    • 84861981022 scopus 로고    scopus 로고
    • Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography
    • de LV, Vergniol J, Foucher J, Merrouche W, Le BB. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int 2012;32:911-8.
    • (2012) Liver Int , vol.32 , pp. 911-918
    • De, L.V.1    Vergniol, J.2    Foucher, J.3    Merrouche, W.4    Le, B.B.5
  • 33
    • 84861961483 scopus 로고    scopus 로고
    • Controlled Attenuation Parameter (CAP): A noninvasive method for the detection of hepatic steatosis based on transient elastography
    • Myers RP, Pollett A, Kirsch R, Pomier-Layrargues G, Beaton M, Levstik M et al. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int 2012;32:902-10.
    • (2012) Liver Int , vol.32 , pp. 902-910
    • Myers, R.P.1    Pollett, A.2    Kirsch, R.3    Pomier-Layrargues, G.4    Beaton, M.5    Levstik, M.6
  • 34
    • 84870819164 scopus 로고    scopus 로고
    • Liver stiffness measurement using XL probe in patients with non-alcoholic fatty liver disease
    • Wong VW, Vergniol J, Wong GL, Foucher J, Chan AW, Chermak F et al. Liver stiffness measurement using XL probe in patients with non-alcoholic fatty liver disease. Am J Gastroenterol 2012;107:1862-71.
    • (2012) Am J Gastroenterol , vol.107 , pp. 1862-1871
    • Wong, V.W.1    Vergniol, J.2    Wong, G.L.3    Foucher, J.4    Chan, A.W.5    Chermak, F.6
  • 35
    • 84155188892 scopus 로고    scopus 로고
    • Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients
    • Myers RP, Pomier-Layrargues G, Kirsch R, Pollett A, Duarte-Rojo A, Wong D et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 2012;55:199-208.
    • (2012) Hepatology , vol.55 , pp. 199-208
    • Myers, R.P.1    Pomier-Layrargues, G.2    Kirsch, R.3    Pollett, A.4    Duarte-Rojo, A.5    Wong, D.6
  • 36
    • 77952529040 scopus 로고    scopus 로고
    • A position statement on NAFID/NASH based on the EASL 2009 special conference
    • Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFID/NASH based on the EASL 2009 special conference. J Hepatol 2010;53:372-84.
    • (2010) J Hepatol , vol.53 , pp. 372-384
    • Ratziu, V.1    Bellentani, S.2    Cortez-Pinto, H.3    Day, C.4    Marchesini, G.5
  • 39
    • 34247525006 scopus 로고    scopus 로고
    • The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies
    • Huang JF, Hsieh MY, Dai CY, Hou NJ, Lee LP, Lin ZY et al. The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies. Gut 2007;56:736-7.
    • (2007) Gut , vol.56 , pp. 736-737
    • Huang, J.F.1    Hsieh, M.Y.2    Dai, C.Y.3    Hou, N.J.4    Lee, L.P.5    Lin, Z.Y.6
  • 40
    • 0028913123 scopus 로고
    • Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: An audit by the British Society of Gastroenterology and the Royal College of Physicians of London
    • Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 1995;36:437-41.
    • (1995) Gut , vol.36 , pp. 437-441
    • Gilmore, I.T.1    Burroughs, A.2    Murray-Lyon, I.M.3    Williams, R.4    Jenkins, D.5    Hopkins, A.6
  • 41
    • 0022647490 scopus 로고
    • Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies
    • Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986;2:165-73. (Pubitemid 16125908)
    • (1986) Journal of Hepatology , vol.2 , Issue.2 , pp. 165-173
    • Piccinino, F.1    Sagnelli, E.2    Pasquale, G.3
  • 42
    • 0017927812 scopus 로고
    • Liver biopsy: Complications in 1000 inpatients and outpatients
    • Perrault J, McGill DB, Ott BJ, Taylor WF. Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology 1978;74:103-6. (Pubitemid 8248893)
    • (1978) Gastroenterology , vol.74 , Issue.1 , pp. 103-106
    • Perrault, J.1    McGill, D.B.2    Ott, B.J.3    Taylor, W.F.4
  • 43
    • 0025119535 scopus 로고
    • A 21-year experience with major hemorrhage after percutaneous liver biopsy
    • McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990;99:1396-400. (Pubitemid 20381876)
    • (1990) Gastroenterology , vol.99 , Issue.5 , pp. 1396-1400
    • McGill, D.B.1    Rakela, J.2    Zinsmeister, A.R.3    Ott, B.J.4
  • 46
    • 78649433367 scopus 로고    scopus 로고
    • Histopathology of non-alcoholic fatty liver disease
    • Brunt EM, Tiniakos DG. Histopathology of non-alcoholic fatty liver disease. World J Gastroenterol 2010;16:5286-96.
    • (2010) World J Gastroenterol , vol.16 , pp. 5286-5296
    • Brunt, E.M.1    Tiniakos, D.G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.